Lee T. Schalop - 19 Aug 2025 Form 4 Insider Report for Lantern Pharma Inc. (LTRN)

Role
Director
Signature
/s/ Lee T. Schalop
Issuer symbol
LTRN
Transactions as of
19 Aug 2025
Net transactions value
$0
Form type
4
Filing time
20 Aug 2025, 18:25:16 UTC
Previous filing
30 Jul 2025
Next filing
13 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Schalop Lee Troy Director 1920 MCKINNEY AVENUE, 7TH FLOOR, DALLAS /s/ Lee T. Schalop 20 Aug 2025 0002072339

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LTRN Stock Option (Right to Buy) Award $0 +5,000 $0.000000 5,000 19 Aug 2025 Common Stock 5,000 $4.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Equity Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 36-month period commencing September 19, 2025.